INSULIN LISPRO MARKET ANALYSIS

Insulin Lispro Market, By Product Type of Insulin Lispro (Insulin Lipro pre-filled pen, Insulin lispro solution vials, Insulin lispro solution cartridge), By Indication (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes, Others), By Age Group (Pediatric Patients, Adult Patients, Geriatric Patients), By Drug Class (Humalog (Eli Lilly and Company), Admelog (Sanofi) and Other brands), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Oct 2023
Code : CMI5719
Pages :173
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Eli Lilly and Company, Sanofi, Novo Nordisk A/S, Merck & Co., Inc., Pfizer Inc., Hoffmann-La Roche Ltd., AstraZeneca PLC, Johnson & Johnson Services, Inc., Biocon Limited, Mylan N.V., Boehringer Ingelheim International GmbH, Wockhardt Ltd., Lupin Pharmaceuticals, Inc., Bioton S.A., Gan & Lee Pharmaceuticals and Ypsomed AG

Top companies in Insulin Lispro Market